ICAM1 and chronic obstructive pulmonary disease: Clinical studies have demonstrated an elevated level of serum soluble (s)ICAM-1 in COPD-smokers (n = 142) compared to non-COPD active smokers (n = 55) (Lopez-Campos et al. 2012).